Analytical Biosciences (China)

Analytical Biosciences (Abiosciences) is a China-based drug target and therapeutic discovery company that harnesses single-cell genomics and bioinformatics to gain molecular insights into human diseases. According to its official website, the company describes itself as a drug target and therapeutic discovery company, offering customized solutions that accelerate breakthrough discoveries. Its core activities span single-cell and spatial omics, bioinformatics, and datasets and platforms, providing an end-to-end solution from single-cell genomics to bioinformatics. The company positions itself as helping to navigate research with cutting-edge algorithms and solid scientific methodologies, and it offers a one-stop solution from single cell genomics to bioinformatics. Its mission is to bring breakthrough discoveries and first-in-class therapeutics to patients through innovative single-cell bioinformatics and multi-omics. Abiosciences operates a two-fold partnership approach: first, it collaborates with biotechnology and pharmaceutical companies to co-investigate its extensive single-cell genomics database and key clinical insights, facilitating rapid target discovery and validation on mutually beneficial deal terms; second, it directly out-licenses validated targets and therapeutic antibodies associated with those targets for clinical development. The company is headquartered in Beijing, China, and its website is abiosciences.com. It presents itself as a discovery-stage company focused on accelerating research and therapeutic development through data-driven approaches.

Analytical Biosciences (Abiosciences) is a company based in Beijing, China, focused on drug target and therapeutic discovery through single-cell genomics and bioinformatics. Public information about its founding and early history is limited. According to its official website, the company operates at the intersection of single-cell genomics, spatial omics, and bioinformatics, offering customized solutions to accelerate breakthrough discoveries. Its stated mission is to bring breakthrough discoveries and first-in-class therapeutics to patients by innovative single-cell bioinformatics and multi-omics. The company provides a one-stop solution from single cell genomics to bioinformatics, and it has developed datasets and platforms that it describes as providing the fastest way to discover and evaluate biomarkers and drug targets. Abiosciences pursues a partnership model: it collaborates with biotechnology and pharmaceutical companies to co-investigate its single-cell genomics database and clinical insights, and it out-licenses validated targets and associated therapeutic antibodies for clinical development. As of the available evidence, the company is active and headquartered in Beijing, China.

A drug target and therapeutic discovery company leveraging single-cell genomics and bioinformatics to accelerate breakthrough discoveries and first-in-class therapeutics.

• Single Cell & Spatial Omics

  End-to-end single-cell and spatial solutions from samples to data to insights.

• Bioinformatics

  Designing powerful strategies to render single-cell data into clear scientific insight.

• Datasets & Platforms

  Providing the fastest way to discover and evaluate biomarkers and drug targets.

1. 1Home - Abiosciencesabiosciences.com
2. 2Analytical Biosciences (China) - Wikidatawikidata.org